Santhera Pharmaceuticals Holding AG (SWX:SANN)

SWX:SANN Balance Sheet

Financials in millions CHF. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	40.93	30.37	1.35	21.21	12.41
Cash & Short-Term Investments	40.93	30.37	1.35	21.21	12.41
Cash Growth	34.76%	2144.64%	-93.62%	70.88%	-60.42%
Accounts Receivable	9.06	0.44	0.44	0.96	2.32
Other Receivables	4.83	1.72	0.65	0.97	2.16
Receivables	13.89	2.16	1.09	1.94	4.49
Inventory	17.53	1.81	0.11	0.43	0.48
Prepaid Expenses	0.37	0.32	0.51	1.07	0.34
Other Current Assets	3.1	-	-	-	-
Total Current Assets	75.81	34.66	3.07	24.64	17.72
Property, Plant & Equipment	2.57	0.58	1.01	1.32	1.9
Long-Term Investments	0.25	0.42	0.44	0.47	0.55
Other Intangible Assets	68.95	73.97	59.21	64.6	67.67
Long-Term Deferred Tax Assets	-	-	0	0.09	0.84
Other Long-Term Assets	4.91	-	-	-	-
Total Assets	152.49	109.63	63.73	91.12	88.69
Accounts Payable	5.75	3.56	3.9	2.41	3.8
Accrued Expenses	19.35	9.57	10.85	9.71	8.65
Short-Term Debt	-	-	22.13	1.49	10.6
Current Portion of Long-Term Debt	6.4	20.94	-	13.88	-
Current Portion of Leases	0.55	0.57	0.62	0.61	0.77
Current Income Taxes Payable	0.14	0.18	0.55	0.27	0.06
Current Unearned Revenue	0.06	-	-	-	1.13
Other Current Liabilities	13.9	10.97	11.36	4.42	4.07
Total Current Liabilities	46.14	45.79	49.41	32.78	29.07
Long-Term Debt	31.73	-	21.08	25.8	57.88
Long-Term Leases	1.94	0.04	0.61	1.2	1.93
Long-Term Unearned Revenue	1.93	-	-	-	-
Other Long-Term Liabilities	35.38	-	34.47	25.21	-
Total Liabilities	124.79	49.69	107.41	89.79	95.04
Common Stock	1.34	1.26	0.75	54.61	19.43
Retained Earnings	-614.69	-572.72	-627.5	-556.43	-500.9
Treasury Stock	-0.07	-0.13	-0.09	-5.02	-1.58
Comprehensive Income & Other	641.11	631.53	583.16	508.17	476.7
Shareholders' Equity	27.7	59.94	-43.69	1.33	-6.35
Total Liabilities & Equity	152.49	109.63	63.73	91.12	88.69
Total Debt	40.62	21.55	44.44	42.98	71.17
Net Cash (Debt)	0.31	8.82	-43.08	-21.77	-58.76
Net Cash Growth	-96.54%	-	-	-	-
Net Cash Per Share	0.03	0.81	-7.07	-6.37	-44.12
Filing Date Shares Outstanding	12.79	11.32	6.59	4.96	1.81
Total Common Shares Outstanding	12.79	11.32	6.59	4.96	1.81
Working Capital	29.67	-11.14	-46.35	-8.14	-11.35
Book Value Per Share	2.17	5.30	-6.63	0.27	-3.50
Tangible Book Value	-41.25	-14.02	-102.89	-63.27	-74.03
Tangible Book Value Per Share	-3.22	-1.24	-15.62	-12.76	-40.83
Machinery	1.46	1.35	1.46	1.82	1.92
Leasehold Improvements	1.48	1.48	1.5	1.54	1.63

Updated Sep 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.